Prognostic relevance of B-type natriuretic peptide in patients with moderate mixed aortic valve disease.
Hirokazu OnishiToru NaganumaMasaki IzumoToru OuchiHaruhito YukiSatoru MitomoSunao NakamuraPublished in: ESC heart failure (2022)
Patients with moderate MAVD are at higher risk of unfavourable clinical outcomes, and age and BNP are independently related to the occurrence of adverse events. High BNP levels may reflect extravalvular cardiac damage in patients with moderate MAVD.